Skip to main content

Table 5 Clinical factors affecting hospital mortality

From: Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients

  Univariable Multivariable
Crude OR 95% CI P value Adjusted OR 95% CI P value
Age 1.06 1.01–1.10 0.011 1.07 1.01–1.14 0.034
Gender 0.43 0.12–1.50 0.184 0.80 0.10–6.06 0.826
SAPS 3 1.05 1.00–1.10 0.033 1.05 0.98–1.13 0.149
Serum albumin, g/dL 0.47 0.18–1.26 0.133 0.58 0.13–2.56 0.469
Cytomegalovirus co-infection 5.50 1.44–20.96 0.013 3.19 0.52–19.63 0.212
Bacterial co-infection 3.65 0.82–16.19 0.089 2.90 0.34–24.32 0.327
Time to anti-PCP treatment, hour 1.00 0.99–1.01 0.939 1.01 0.99–1.02 0.307
Failure to initial treatment 8.38 2.36–29.74 0.001 14.12 2.23–89.38 0.005
  1. OR odds ratio, CI confidence interval, SAPS Simplified Acute Physiology Score 3, PCP Pneumocystis pneumonia